TISSUE REGENIX GRP. ORD 0.1P news, videos and press releases
For more news please use our advanced search feature.
TISSUE REGENIX GRP. ORD 0.1P - More news...
TISSUE REGENIX GRP. ORD 0.1P - More news...
- Hardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative
- Hardman & Co Research on Tissue Regenix (TRX): Operating leverage
- Hardman & Co Research: Q&A on Tissue Regenix Group plc: Significantly undervalued which should correct
- Hardman & Co Research : Tissue Regenix (TRX): Strong 1H’22 sales suggest upside potential
- Hardman & Co Research: Tissue Regenix (TRX) On pathway to sustainability
- Hardman & Co Research: Tissue Regenix (TRX): Faster-than-anticipated recovery
- Hardman & Co Research: Q&A with Dr Martin Hall on Tissue Regenix Group Plc: New capacity now on stream
- Hardman & Co Research: Tissue Regenix (TRX): Poised for growth
- Hardman & Co Research: Tissue Regenix (TRX): Funded through to profitability
- Hardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
- Hardman & Co Research: Tissue Regenix (TRX): Credit facilities expand cash runway to 2021
- Hardman & Co Research: Tissue Regenix (TRX): Expanded GPO coverage secured
- Hardman & Co Research: Tissue Regenix (TRX): 2018 in review: foundations laid for osteobiologics
- Hardman & Co Research: Tissue Regenix (TRX): Strategy delivering growth above expectations
- Hardman & Co Research: Tissue Regenix (TRX): 1H'18 preview: organic plus inorganic growth
- Hardman & Co Research: Tissue Regenix (TRX): CellRight hits the right note
-
Tissue Regenix Group
-
Tissue Regenix Group
